# MOMA Therapeutics

**Canonical:** https://apis.io/providers/moma-therapeutics/  
**Website:** https://momatx.com/  
**APIs profiled:** 10

MOMA Therapeutics is a Cambridge, Massachusetts drug-discovery company founded in 2020 that builds precision medicines against molecular machines — the highly dynamic proteins that convert chemical energy stored in cells into regulatory work such as protein transport, DNA repair and degradation, and whose constant conformational shape-shifting has historically made them undruggable. Its proprietary KNOMATIC platform combines advanced structural frameworks and functional-genomics target validation with high-throughput fragment and DNA-encoded-library screening, CRISPR gene editing, artificial intelligence for detecting dynamic conformational patterns, and machine-learning lead optimisation, all built against a continually expanding structure-function knowledge base. The company launched in April 2020 with an $86 million Series A led by Third Rock Ventures, added a $150 million Series B in May 2022, and has taken two wholly owned oncology assets into the clinic: MOMA-313, a selective inhibitor of the polymerase theta (Polθ) helicase domain for homologous- recombination-deficient tumours, which entered Phase 1 in August 2024; and MOMA-341, a potent and selective WRN helicase inhibitor for microsatellite-unstable and TA-repeat-expanded tumours, which dosed its first Phase 1 patient in July 2025. It also runs a five-year discovery collaboration with Roche announced in January 2024, an oncology collaboration and licence agreement with Bayer signed in October 2024, and an exclusive licence for a selective PARP1 inhibitor announced in January 2025. MOMA Therapeutics runs no developer program and publishes no product API, developer portal, API reference or machine-readable specification. The only machine-readable surface reachable without credentials is the WordPress REST content API behind momatx.com, catalogued here.

## Kin Score — 32.3 / 100 (thin)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 32.3).

| Facet | Score |
|---|---|
| Discoverability | 74.1 |
| Contract Quality | 53.4 |
| Governance | 18.2 |
| Contract Governance | 18.2 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 16.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 31.3 (matched via tags).

## Agent readiness — 24.3 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | bearer |
| Idempotency | no |
| Error Semantics | documented |
| OpenAPI Examples | partial |
| Rate Limit Signal | documented |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Open access — onboarding: open, pricing: unknown, trial: no (confidence: medium).

## APIs (10)

- **MOMA Therapeutics Content Posts API** — News archive — company press releases, media coverage, peer-reviewed publications and conference presentations (32 published at harvest time, spanning April 2020 through August ...
- **MOMA Therapeutics Content Pages API** — Corporate pages — Science, Pipeline, MOMA, Team, Join Us, News Feed, Privacy Policy and Terms (9 published at harvest time). The acf.modules flexible-content array carries the p...
- **MOMA Therapeutics Team API** — The team custom post type — leadership, board of directors, scientific advisory board and founders (59 published records at harvest time), classified by the MOMA-specific team_t...
- **MOMA Therapeutics Media API** — Media library — AACR conference posters, publication PDFs, headshots, logos and site imagery (211 attachments at harvest time).
- **MOMA Therapeutics Taxonomy API** — Term collections for the three registered taxonomies — category (4 terms including Blog and Press Release), post_tag (registered but empty) and the MOMA-specific team_types (3 t...
- **MOMA Therapeutics Discovery API** — Self-describing metadata — the 219-route index across 12 namespaces, plus registered post types, taxonomies and statuses. This is the only machine-readable contract the company ...
- **MOMA Therapeutics Search API** — Cross-content search over every published object — posts, pages and team records. An unfiltered query returned 42 results at harvest time.
- **MOMA Therapeutics Comments API** — Comment collection. Registered and anonymously reachable, but empty — no object on this deployment carries comments.
- **MOMA Therapeutics oEmbed API** — oEmbed 1.0 provider endpoint for momatx.com URLs, returning rich embeddable responses.
- **MOMA Therapeutics Site Options API** — Advanced Custom Fields options-page payload, anonymously readable at /acf/v3/options/options. It carries site-wide configuration — logo, footer contact block, social profile URL...

## Security (2)

- **Moma Therapeutics Authentication** — 0 schemes
- **Moma Therapeutics Domain Security** — TLSv1.3 · DMARC

## Plans (1)

- **Moma Therapeutics Plans Pricing**

## Tags

Company, Biotechnology, Pharmaceuticals, Drug Discovery, Oncology, Precision Medicine, Life Sciences, Structural Biology, Machine-Learning, content-api

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/moma-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.